New Combo Shows Benefit Even in Patients With High-Risk HCC

Updated data continue to show significant clinical benefits for patients with unresectable hepatocellular carcinoma (HCC) with the combination of the

Read more

Adverse Reactions to Immunotherapy Can Appear After a Year

Clinicians should be on the lookout for immune-related adverse reactions (irAEs) even after patients have been receiving anti–programmed cell death

Read more

Deadly Brain Tumor: Survival Extended by Oncolytic Virus Product

An experimental immunotherapy that contains a genetically altered version of herpes simplex virus type 1 (HSV-1) was associated with a

Read more